Q3 2017 Holdings
Filed 2017-11-01 | 7 holdings | $458.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-06-06) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV)A | Common | 00287Y109 | $344.4M | 3,875,358 | 75.1% |
| Biogen Inc(BIIB)A | Common | 09062X103 | $112.8M | 360,084 | 24.6% |
| Prothena Corp PLC(PRTA)A | SHS | G72800108 | $735.1K | 11,349,614 | 0.2% |
| Alkermes PLC(ALKS)A | SHS | G01767105 | $372.9K | 7,335,683 | 0.1% |
| Theravance Biopharma Inc(TBPH)A | Common | G8807B106 | $366.6K | 10,706,108 | 0.1% |
| Gilead Sciences Inc(GILD)A | Common | 375558103 | $134.9K | 1,665,592 | 0.0% |
| Bioverativ IncA | Common | 09075E100 | $111.9K | 1,960,325 | 0.0% |